This executive report examines the growing margin pressures facing medical device manufacturers and argues that pricing governance has become a strategic issue requiring board-level attention. The report highlights how rising costs, supply chain instability, tariff changes, distributor influence, and increasing competitive pressures have transformed margin risk from a temporary challenge into a persistent structural concern. With the Producer Price Index for medical equipment and supplies reaching record highs, manufacturers must manage increasingly complex product portfolios while protecting profitability. The report emphasizes the importance of stronger pricing governance, improved visibility into pricing decisions, and greater alignment between pricing strategy and business objectives.

Join for free to read